Vimarsana
Biggest News Aggregation in the World

Page 2 - Dario Elevate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dario Elevate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dario Elevate Today - Breaking & Trending Today

DarioHealth (NASDAQ:DRIO) & Medigus (NASDAQ:MDGS) Critical Survey - Vimarsana News

DarioHealth (NASDAQ:DRIO) & Medigus (NASDAQ:MDGS) Critical Survey

Medigus (NASDAQ:MDGS – Get Free Report) and DarioHealth (NASDAQ:DRIO – Get Free Report) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends and risk. Analyst Ratings This is a breakdown of recent […]

Critical Survey: DarioHealth (NASDAQ:DRIO) versus Medigus (NASDAQ:MDGS) - Vimarsana News

Critical Survey: DarioHealth (NASDAQ:DRIO) versus Medigus (NASDAQ:MDGS)

Medigus (NASDAQ:MDGS – Get Free Report) and DarioHealth (NASDAQ:DRIO – Get Free Report) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations. Volatility & Risk Medigus has a beta of […]

DarioHealth (NASDAQ:DRIO) Announces Quarterly Earnings Results - Vimarsana News

DarioHealth (NASDAQ:DRIO) Announces Quarterly Earnings Results

DarioHealth (NASDAQ:DRIO – Get Free Report) announced its earnings results on Thursday. The company reported ($0.58) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.52) by ($0.06), reports. DarioHealth had a negative net margin of 120.19% and a negative return on equity of 39.85%. The business had revenue of $6.15 million during […]

Rigorous Data Are Key to Convince Payers, Investors in the World of Digital Therapeutics - Vimarsana News

Rigorous Data Are Key to Convince Payers, Investors in the World of Digital Therapeutics

Pear Therapeutics was once regarded as a digital therapeutics pioneer, but its spiral into bankruptcy has the industry searching for the best path forward. While some favor going direct to consumers, others say the solution is in generating more robust clinical trial data to persuade hesitant payers.